Your browser doesn't support javascript.
loading
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Martin-Broto, Javier; Valverde, Claudia; Hindi, Nadia; Vincenzi, Bruno; Martinez-Trufero, Javier; Grignani, Giovanni; Italiano, Antoine; Lavernia, Javier; Vallejo, Ana; Tos, Paolo Dei; Le Loarer, Francois; Gonzalez-Campora, Ricardo; Ramos, Rafael; Hernández-Jover, Diana; Gutierrez, Antonio; Serrano, Cesar; Monteagudo, Maria; Letón, Rocio; Robledo, Mercedes; Moura, David S; Martin-Ruiz, Marta; López-Guerrero, Jose A; Cruz, Julia; Fernandez-Serra, Antonio; Blay, Jean-Yves; Fumagalli, Elena; Martinez-Marin, Virginia.
Afiliação
  • Martin-Broto J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain. jmartin@atbsarc.org.
  • Valverde C; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain. jmartin@atbsarc.org.
  • Hindi N; General de Villalba University Hospital, 28400, Madrid, Spain. jmartin@atbsarc.org.
  • Vincenzi B; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Martinez-Trufero J; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.
  • Grignani G; Medical Oncology Department, Fundación Jimenez Diaz University Hospital, Av. de los Reyes Católicos, 2, 28040, Madrid, Spain.
  • Italiano A; General de Villalba University Hospital, 28400, Madrid, Spain.
  • Lavernia J; Medical Oncology, University Campus Bio-Medico and Fondazione Policlinico Universitario Campus Bio-Medico, 00128, Rome, Italy.
  • Vallejo A; Medical Oncology Department, University Hospital Miguel Servet, 50009, Zaragoza, Spain.
  • Tos PD; Medical Oncology Unit, Città della Salute e della Scienza Hospital, 10126, Turin, Italy.
  • Le Loarer F; Medical Oncology department, Institute Bergonié, 33076, Bordeaux, France.
  • Gonzalez-Campora R; Medical Oncology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain.
  • Ramos R; Pathology department, Hospital Regional Universitario de Malaga, 29010, Malaga, Spain.
  • Hernández-Jover D; Department of Medicine, School of Medicine, University of Padua, 35122, Padua, Italy.
  • Gutierrez A; Pathology department, Institute Bergonié, 33076, Bordeaux, France.
  • Serrano C; Pathology department, Hospital Quironsalud, 14004, Cordoba, Cordoba, Spain.
  • Monteagudo M; Pathology department, University Hospital Son Espases, 07120, Mallorca, Spain.
  • Letón R; Radiology department, Sant Pau University Hospital, 08025, Barcelona, Spain.
  • Robledo M; Hematology department, University Hospital Son Espases, 07120, Mallorca, Spain.
  • Moura DS; Medical Oncology department, Vall d'Hebron University Hospital, 08035, Barcelona, Spain.
  • Martin-Ruiz M; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • López-Guerrero JA; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Cruz J; Hereditary Endocrine Cancer Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Fernandez-Serra A; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Institute of Health Carlos III (ISCIII), Madrid, Spain.
  • Blay JY; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.
  • Fumagalli E; Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autonoma de Madrid (IIS-FJD, UAM), 28040, Madrid, Spain.
  • Martinez-Marin V; Molecular Biology department, Fundación Instituto Valenciano de Oncologia, 46009, Valencia, Spain.
Mol Cancer ; 22(1): 127, 2023 08 09.
Article em En | MEDLINE | ID: mdl-37559050
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Tumores do Estroma Gastrointestinal / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Tumores do Estroma Gastrointestinal / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Revista: Mol Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha